These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20496257)

  • 21. Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain.
    Inoue M; Ma L; Aoki J; Ueda H
    J Neurochem; 2008 Dec; 107(6):1556-65. PubMed ID: 19014389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery and optimization of boronic acid based inhibitors of autotaxin.
    Albers HM; van Meeteren LA; Egan DA; van Tilburg EW; Moolenaar WH; Ovaa H
    J Med Chem; 2010 Jul; 53(13):4958-67. PubMed ID: 20536182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of small-molecule inhibitors of autotaxin that inhibit melanoma cell migration and invasion.
    Saunders LP; Ouellette A; Bandle R; Chang WC; Zhou H; Misra RN; De La Cruz EM; Braddock DT
    Mol Cancer Ther; 2008 Oct; 7(10):3352-62. PubMed ID: 18852138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autotaxin signaling via lysophosphatidic acid receptors contributes to vascular endothelial growth factor-induced endothelial cell migration.
    Ptaszynska MM; Pendrak ML; Stracke ML; Roberts DD
    Mol Cancer Res; 2010 Mar; 8(3):309-21. PubMed ID: 20197381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autotaxin/lysophospholipase D-mediated lysophosphatidic acid signaling is required to form distinctive large lysosomes in the visceral endoderm cells of the mouse yolk sac.
    Koike S; Keino-Masu K; Ohto T; Sugiyama F; Takahashi S; Masu M
    J Biol Chem; 2009 Nov; 284(48):33561-70. PubMed ID: 19808661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATX-LPA axis induces expression of OPN in hepatic cancer cell SMMC7721.
    Zhang R; Zhang Z; Pan X; Huang X; Huang Z; Zhang G
    Anat Rec (Hoboken); 2011 Mar; 294(3):406-11. PubMed ID: 21337710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, pharmacology, and cell biology of sn-2-aminooxy analogues of lysophosphatidic acid.
    Gajewiak J; Tsukahara R; Fujiwara Y; Tigyi G; Prestwich GD
    Org Lett; 2008 Mar; 10(6):1111-4. PubMed ID: 18284246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.
    Nakasaki T; Tanaka T; Okudaira S; Hirosawa M; Umemoto E; Otani K; Jin S; Bai Z; Hayasaka H; Fukui Y; Aozasa K; Fujita N; Tsuruo T; Ozono K; Aoki J; Miyasaka M
    Am J Pathol; 2008 Nov; 173(5):1566-76. PubMed ID: 18818380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid.
    Inoue M; Xie W; Matsushita Y; Chun J; Aoki J; Ueda H
    Neuroscience; 2008 Mar; 152(2):296-8. PubMed ID: 18280050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development.
    van Meeteren LA; Ruurs P; Stortelers C; Bouwman P; van Rooijen MA; Pradère JP; Pettit TR; Wakelam MJ; Saulnier-Blache JS; Mummery CL; Moolenaar WH; Jonkers J
    Mol Cell Biol; 2006 Jul; 26(13):5015-22. PubMed ID: 16782887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorogenic phospholipid substrate to detect lysophospholipase D/autotaxin activity.
    Ferguson CG; Bigman CS; Richardson RD; van Meeteren LA; Moolenaar WH; Prestwich GD
    Org Lett; 2006 May; 8(10):2023-6. PubMed ID: 16671772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation.
    Albers HM; Dong A; van Meeteren LA; Egan DA; Sunkara M; van Tilburg EW; Schuurman K; van Tellingen O; Morris AJ; Smyth SS; Moolenaar WH; Ovaa H
    Proc Natl Acad Sci U S A; 2010 Apr; 107(16):7257-62. PubMed ID: 20360563
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S32826, a nanomolar inhibitor of autotaxin: discovery, synthesis and applications as a pharmacological tool.
    Ferry G; Moulharat N; Pradère JP; Desos P; Try A; Genton A; Giganti A; Beucher-Gaudin M; Lonchampt M; Bertrand M; Saulnier-Blache JS; Tucker GC; Cordi A; Boutin JA
    J Pharmacol Exp Ther; 2008 Dec; 327(3):809-19. PubMed ID: 18755937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.
    Liu S; Umezu-Goto M; Murph M; Lu Y; Liu W; Zhang F; Yu S; Stephens LC; Cui X; Murrow G; Coombes K; Muller W; Hung MC; Perou CM; Lee AV; Fang X; Mills GB
    Cancer Cell; 2009 Jun; 15(6):539-50. PubMed ID: 19477432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain.
    Inoue M; Ma L; Aoki J; Chun J; Ueda H
    Mol Pain; 2008 Feb; 4():6. PubMed ID: 18261210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ins and outs of lysophosphatidic acid signaling.
    Moolenaar WH; van Meeteren LA; Giepmans BN
    Bioessays; 2004 Aug; 26(8):870-81. PubMed ID: 15273989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.
    Gupte R; Siddam A; Lu Y; Li W; Fujiwara Y; Panupinthu N; Pham TC; Baker DL; Parrill AL; Gotoh M; Murakami-Murofushi K; Kobayashi S; Mills GB; Tigyi G; Miller DD
    Bioorg Med Chem Lett; 2010 Dec; 20(24):7525-8. PubMed ID: 21051230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lysophosphatidic acid is a lipid mediator with wide range of biological activities. Biosynthetic pathways and mechanism of action.
    Berdichevets IN; Tyazhelova TV; Shimshilashvili KhR; Rogaev EI
    Biochemistry (Mosc); 2010 Sep; 75(9):1088-97. PubMed ID: 21077828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammary tumorigenesis through LPA receptor signaling.
    Jonkers J; Moolenaar WH
    Cancer Cell; 2009 Jun; 15(6):457-9. PubMed ID: 19477423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: relevance to prostate cancer and benign hyperplasia.
    Zeng Y; Kakehi Y; Nouh MA; Tsunemori H; Sugimoto M; Wu XX
    Prostate; 2009 Feb; 69(3):283-92. PubMed ID: 19025891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.